반응식
[F:1][C:2]1[CH:7]=[CH:6][C:5]([NH2:8])=[CH:4][CH:3]=1.C1N=CN([C:14](N2C=NC=C2)=[O:15])C=1.[CH2:21]([O:23][C:24](=[O:43])[CH2:25][CH2:26][C:27]1[CH:32]=[CH:31][CH:30]=[C:29]([N:33]2[C:37]([NH2:38])=[CH:36][C:35]([C:39]([CH3:42])([CH3:41])[CH3:40])=[N:34]2)[CH:28]=1)[CH3:22].O>CN(C=O)C>[CH2:21]([O:23][C:24](=[O:43])[CH2:25][CH2:26][C:27]1[CH:32]=[CH:31][CH:30]=[C:29]([N:33]2[C:37]([NH:38][C:14]([NH:8][C:5]3[CH:6]=[CH:7][C:2]([F:1])=[CH:3][CH:4]=3)=[O:15])=[CH:36][C:35]([C:39]([CH3:42])([CH3:41])[CH3:40])=[N:34]2)[CH:28]=1)[CH3:22]참가 물질
반응물 4
생성물 1
시약·촉매·용매 1
실험 절차
A solution of 4-fluoro-phenylamine (111 mg, 1.0 mmol) and CDI (165 mg, 1.0 mmol) in DMF (2 mL) was stirred at RT for 30 min, and was then added to a solution of Example Z (315 mg, 1.0 mmol) in DMF (2 mL). The resulting mixture was stirred at RT overnight then added to water (50 mL). The reaction mixture was extracted with ethyl acetate (3×50 mL) and the combined organic extracts were washed with brine, dried (NaSO4) and filtered. After concentrated under reduced pressure, the residue was purified by flash chromatography to afford 3-(3-{3-t-butyl-5-[3-(4-fluoro-phenyl)-ureido]-pyrazol-1-yl}-phenyl)-propionic acid ethyl ester (150 mg, 33%). 1H-NMR (CDCl3): 7.91 (s, 1H), 7.42 (d, J=4.8 Hz, 1H), 7.37-7.34 (m, 2H), 7.28 (s, 1H), 7.17-7.16 (m, 2H), 6.98 (t, J=8.8 Hz, 2H), 6.59 (s, 1H), 4.04 (q, J=7.2 Hz, 2H), 3.03 (t, J=7.2 Hz, 2H), 2.77 (t, J=7.2 Hz, 2H), 1.36 (s, 9H), 1.17 (t, J=7.2 Hz, 3H); MS (ESI) m/z: 453 (M+H+).
후처리
- extractionThe reaction mixture was extracted with ethyl acetate (3×50 mL)
- washthe combined organic extracts were washed with brine
- dry with materialdried (NaSO4)
- filtrationfiltered
- concentrationAfter concentrated under reduced pressure
- customthe residue was purified by flash chromatography
출처 및 근거
- ORD 기록
- ord-ba5911e4bc59464b9a2faab7173a5a1f
- 출처 데이터셋
- uspto-grants-2009_05
- 특허 번호
- US07531566B2
연결된 노트
불러오는 중…